Lataa...
PD-1 Blockade in Chinese versus Western Patients with Melanoma
In this trial of PD-1 blockade with toripalimab in previously-treated Chinese patients with melanoma, unique histologic and molecular features may explain why the objective response rate is lower than those defined in Western populations. This work suggests future avenues for investigating mechanism...
Tallennettuna:
| Julkaisussa: | Clin Cancer Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7442612/ https://ncbi.nlm.nih.gov/pubmed/32487680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-1558 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|